Avanos Medical, Inc. Financial Ratios — AVNS Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	694.87	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	12.04	6.16	1.08	-18.87	1.95	3.72	2.85	-2.53	-1.57	0.38	2.98	-3.55	-27.55	-6.54
Return on Capital (%)	- -	403.51	352.32	8.94	- -	- -	- -	- -	- -	- -	- -	-128.4	- -	- -	- -
Return on Invested Capital (%)	- -	14.08	7.19	1.32	- -	- -	- -	- -	- -	- -	- -	1.88	- -	- -	- -
Gross Margin (%)	35.59	35.78	36.49	32.81	50.65	52.49	55.09	59.93	57.65	52.22	50.97	57.62	56.39	55.44	50.47
EBITDA Margin (%)	15.77	16.96	17.56	10.75	-13.81	-7.4	2.68	5.21	-2.69	-0.45	-0.12	12.16	7.47	12.5	7.74
Operating Margin (%)	12.69	13.54	13.43	5.64	-26.66	-18.92	-7.05	0.08	-7.98	-6.45	-6.64	5.19	0.62	5.89	2.2
Incremental Operating Margin (%)	- -	71.78	41.54	2,425.93	- -	- -	- -	107.13	- -	- -	- -	76.73	289.81	250.34	-187.31
Pretax Margin (%)	12.93	13.65	13.58	5.45	-33.1	-24.58	-11.81	-2.77	-9.17	-8.46	-7.17	3.9	-1.17	-58.64	-9.44
Profit Margin (%)	8.58	9.06	9.22	1.62	-83.75	7.03	12.97	8.81	-6.58	-3.81	1.07	7.38	-9.18	-57.01	-10.4
Net Income to Common Margin (%)	8.58	9.06	9.22	1.62	-83.75	7.03	12.97	8.81	-6.58	-3.81	1.07	7.38	-9.18	-57.01	-10.4
Effective Tax Rate (%)	33.64	33.59	32.13	70.29	- -	- -	- -	- -	- -	- -	- -	19.48	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	2,509.23	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	-16,741.03	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

MCP API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	76	12	626	578	579	581	248	325	249	188	277	209	170	129
ST Debt	- -	76	12	4	- -	- -	40	- -	15	16	15	18	21	20	18
LT Debt	- -	- -	- -	623	578	579	541	248	311	233	173	259	188	150	111
Total Debt/EBITDA	- -	0.27	0.04	3.49	-8.22	-13.82	35.42	7.29	-17.31	-77.75	-267.86	3.33	4.16	1.98	2.38
Net Debt/EBITDA	- -	0.1	-0.11	2.66	-6.38	-11.11	22.02	-4.02	-2.28	-21.41	-16.43	1.26	1.6	0.31	0.2
Total Debt/EBIT	- -	0.33	0.05	6.64	-4.26	-5.41	-13.48	495.4	-5.84	-5.4	-4.81	7.8	49.79	4.2	8.38
Net Debt/EBIT	- -	0.12	-0.14	5.06	-3.31	-4.34	-8.38	-273.6	-0.77	-1.49	-0.29	2.95	19.12	0.67	0.69
EBITDA to Interest Expense	1,309	357	2,945	29.95	-2.12	-1.28	0.52	1.29	-1.25	-0.21	-0.21	8.32	3.35	7.05	6.96
EBITDA-CapEx/Interest Expense	1,309	357	2,945	29.95	-2.12	-1.28	0.52	1.29	-1.25	-0.21	-0.21	8.32	3.35	7.05	6.96
EBIT to Interest Expense	1,053.5	285	2,253	15.72	-4.1	-3.28	-1.36	0.02	-3.71	-2.96	-11.82	3.55	0.28	3.32	1.97
Interest Expense	- -	1	- -	6	33	33	32	26	15	16	3	10	15	12	8
Common Equity/Total Assets	- -	- -	- -	0.31	-20.92	-18.28	-13.63	-13.19	-15.99	-18.83	-18.9	-14.14	-18.58	-61.21	-72.59
Long-Term Debt/Equity (%)	- -	- -	- -	41.75	54.78	52.52	44.52	19.09	24.56	18.57	13.6	20.04	15.18	18.09	14.23
Long-Term Debt/Capital (%)	- -	- -	- -	98.16	362.22	289.07	192.22	4,270.69	826.33	-352.42	-149.48	1,060.66	-178.25	-27.95	-17.02
Long-Term Debt/Total Assets (%)	- -	- -	- -	24.73	28.9	27.95	24.64	13.51	17.26	13.95	10.78	14.48	11.09	12.99	10.31
Total Debt/Equity (%)	- -	3.69	0.57	42.01	54.78	52.52	47.79	19.09	25.72	19.8	14.76	21.45	16.91	20.54	16.59
Total Debt/Capital (%)	- -	100	100	98.77	362.22	289.07	206.36	4,270.69	865.43	-375.83	-162.2	1,135.25	-198.58	-31.74	-19.85
Total Debt/Total Assets (%)	- -	3	0.48	24.88	28.9	27.95	26.45	13.51	18.08	14.87	11.69	15.5	12.36	14.75	12.02
Net Debt to Equity	- -	1.36	-1.55	32.02	42.51	42.2	29.72	-10.55	3.38	5.45	0.91	8.12	6.5	3.26	1.37
Net Debt/Capital (%)	- -	100	100	98.39	1,490.37	537.3	584.47	36.12	-25.52	-38.55	-4.91	-101.45	-41.61	-4.19	-1.45
EBITDA	262	286	294	180	-70	-42	16	34	-19	-3	-1	83	50	86	54
EBITDA-CapEx	262	286	294	180	-70	-42	16	34	-19	-3	-1	83	50	86	54
Operating Income (Loss)	211	228	225	94	-136	-107	-43	- -	-56	-46	-39	36	4	40	15

Liquidity (USD)

MCP API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	- -	0.13	0.14	0.42	0.41	0.35	0.56	1.45	0.97	0.67	0.85	0.67	0.37	0.65	0.54
Current Ratio	- -	1.65	1.88	1.92	2.14	1.83	2.98	2.7	2.53	2.81	3.07	3.27	2.08	2.37	2.15
Quick Ratio	- -	0.64	0.8	1.08	1.12	0.93	1.08	2.02	1.74	1.68	1.79	1.55	0.98	1.45	1.17
CFO/Avg Current Liab	- -	1.13	0.67	0.44	0.29	0.59	0.4	-0.45	-0.31	-0.01	0.57	0.55	0.15	0.5	0.45
Common Equity/Total Assets	- -	- -	- -	0.31	-20.92	-18.28	-13.63	-13.19	-15.99	-18.83	-18.9	-14.14	-18.58	-61.21	-72.59
Long-Term Debt/Equity (%)	- -	- -	- -	41.75	54.78	52.52	44.52	19.09	24.56	18.57	13.6	20.04	15.18	18.09	14.23
Long-Term Debt/Capital (%)	- -	- -	- -	98.16	362.22	289.07	192.22	4,270.69	826.33	-352.42	-149.48	1,060.66	-178.25	-27.95	-17.02
Long-Term Debt/Total Assets (%)	- -	- -	- -	24.73	28.9	27.95	24.64	13.51	17.26	13.95	10.78	14.48	11.09	12.99	10.31
Total Debt/Equity (%)	- -	3.69	0.57	42.01	54.78	52.52	47.79	19.09	25.72	19.8	14.76	21.45	16.91	20.54	16.59
Total Debt/Capital (%)	- -	100	100	98.77	362.22	289.07	206.36	4,270.69	865.43	-375.83	-162.2	1,135.25	-198.58	-31.74	-19.85
Total Debt/Total Assets (%)	- -	3	0.48	24.88	28.9	27.95	26.45	13.51	18.08	14.87	11.69	15.5	12.36	14.75	12.02
CFO/Total Liabilities	- -	42.34	55.27	14.41	10.33	19.48	14.71	-27.15	-13.94	-0.6	26.22	18.34	7.1	30.92	25.28
CFO/CapEx	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Altman's Z-Score	- -	2.94	3.01	3.66	0.89	1.07	2.08	3.33	2.42	3.84	3.58	2.76	2.21	1.53	0.86

Working Capital (USD)

MCP API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	18.33	8.67	7.65	2.22	2.74	3.12	3.69	4.61	5.48	5.18	5	4.73	5.36	6.06
Days Sales Outstanding	- -	19.91	42.1	47.72	164.43	133.18	116.82	98.9	79.24	66.64	70.51	73.07	77.09	68.09	60.28
Inventory Turnover	- -	7.17	3.63	3.95	0.86	1.4	3.2	2.46	2.21	2.17	1.75	1.99	1.99	2.03	2.42
Days Inventory Outstanding	- -	50.91	100.61	92.38	425.95	260.45	114.14	148.36	165.14	168.23	208.12	183.57	183.68	179.82	150.71
Accounts Payable Turnover	- -	27.07	9.51	7.81	1.63	0.29	1.72	1.71	2.53	4.84	4.49	4.23	5.23	5.1	6.49
Accounts Payable Turnover Days	- -	13.48	38.39	46.76	223.26	1,270.83	212.39	213.41	144.28	75.4	81.34	86.29	69.85	71.55	56.21
Cash Conversion Cycle	- -	57.33	104.33	93.34	367.12	-877.19	18.57	33.86	100.1	159.47	197.29	170.35	190.92	176.36	154.78
Inventory to Cash Days	- -	-31	-58.51	-44.66	-261.53	-127.27	2.69	-49.46	-85.9	-101.59	-137.61	-110.5	-106.59	-111.73	-90.43
Inventories	- -	302	286	283	303	81	91	121	146	169	159	132	163	139	148
Raw Materials	- -	55	56	62	62	31	34	47	54	54	54	39	55	39	39
Work In Process	- -	65	65	48	46	16	21	22	31	32	33	24	20	21	25
Finished Goods	- -	206	191	195	212	45	50	64	71	90	72	70	88	78	84
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	9	- -	- -	- -	- -

Enterprise Value (USD)

MCP API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	- -	2,116	1,556	1,723	2,161	2,114	1,604	2,193	1,668	1,269	1,045	732	520
- Cash & Cash Equivalents	- -	48	44	149	130	114	220	384	205	112	118	128	88	108	90
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	76	12	626	578	579	581	248	325	249	188	277	209	170	129
Enterprise Value	- -	28	-32	2,593	2,005	2,189	2,522	1,977	1,724	2,330	1,737	1,418	1,167	795	559
Total Capital	- -	76	12	634	160	200	282	6	38	-66	-116	24	-105	-536	-650
Total Debt/Capital (%)	- -	100	100	98.77	362.22	289.07	206.36	4,270.69	865.43	-375.83	-162.2	1,135.25	-198.58	-31.74	-19.85
Total Debt / EV	- -	2.71	-0.37	0.24	0.29	0.26	0.23	0.13	0.19	0.11	0.11	0.2	0.18	0.21	0.23
EV/Sales	- -	0.02	- -	1.55	3.94	3.87	4.12	3.03	2.47	3.26	2.96	2.07	1.73	1.16	0.8
EV/EBITDA	- -	0.1	- -	14.43	30.66	33.57	153.81	58.16	46.73	54.32	45.34	17.05	23.19	9.24	10.3
EV/EBIT	- -	0.12	- -	27.5	- -	- -	- -	3,954.58	- -	- -	- -	39.96	277.77	19.63	36.31
EV/Cash Flow to Firm	- -	0.14	- -	17.33	17.07	10.5	15.94	- -	- -	516.3	19.36	14.33	22.79	7.07	6.71
EV/Free Cash Flow to Firm	- -	0.14	- -	17.33	17.07	10.5	15.94	- -	- -	516.3	19.36	14.33	22.79	7.07	6.71
Diluted Market Cap	- -	- -	- -	2,116	1,556	1,738	2,161	2,114	1,604	2,193	1,685	1,280	1,045	732	520
Diluted Enterprise Value	- -	28	-32	2,594	2,005	2,203	2,522	1,977	1,724	2,330	1,754	1,429	1,167	795	559
EV per Share	- -	0.6	- -	55.73	43.04	46.96	53.9	41.89	36.22	48.75	36.1	30.24	25.04	17.28	12.08
TTM Sales	1,660	1,684	1,678	1,672	509	566	612	652	698	715	587	684	673	688	701
TTM EBITDA	262	286	294	180	-70	-42	16	34	-19	-3	-1	83	50	86	54
TTM Operating Income	211	228	225	94	-136	-107	-43	- -	-56	-46	-39	36	4	40	15
TTM Cash Flow to Firm	140	203	224	150	117	208	158	-133	-64	5	90	99	51	112	83
TTM Free Cash Flow to Firm	140	203	224	150	117	208	158	-133	-64	5	90	99	51	112	83

Multiples (USD)

MCP API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	- -	14.31	15.95	9.21	14.99	-14.52	-21.53	-877.23	19.3	14.08	32.26	7.27	6.96
EV/EBIT	- -	0.12	- -	27.5	- -	- -	- -	3,954.58	- -	- -	- -	39.96	277.77	19.63	36.31
Enterprise Value	- -	28	-32	2,593	2,005	2,189	2,522	1,977	1,724	2,330	1,737	1,418	1,167	795	559
Low Price	- -	- -	- -	32.81	26.58	22.76	35.24	40.63	31.29	19.46	28.95	19.32	17.24	15.51	9.3
EV/Sales	- -	0.02	- -	1.55	3.94	3.87	4.12	3.03	2.47	3.26	2.96	2.07	1.73	1.16	0.8
EV/EBITDA	- -	0.1	- -	14.43	30.66	33.57	153.81	58.16	46.73	54.32	45.34	17.05	23.19	9.24	10.3
Price/Earnings	- -	- -	- -	78.08	- -	43.3	27.25	36.77	- -	- -	264.7	25.13	- -	- -	- -
Price/Earnings Average	- -	- -	- -	67.32	-4.28	37.54	24.41	44.59	-41.91	-58.24	294.14	25.87	-18.58	-2.39	-8.13
Price/Earnings High	- -	- -	- -	92.47	-5.56	46.29	30.09	59.89	-55.43	-87.87	409.31	33.64	-24.12	-2.98	-11.24
Price/Earnings Low	- -	- -	- -	56.34	-2.9	26.65	20.8	33.35	-32.45	-34.2	221.03	17.94	-13	-1.82	-5.91
Price/Book Value	- -	- -	- -	271.28	-3.72	-4.55	-7.22	-8.74	-5.57	-6.96	-5.5	-5.02	-3.32	-1.04	-0.67
Price/Book Value Average	- -	- -	- -	233.89	-4.36	-3.94	-6.46	-10.6	-6.68	-5.03	-6.11	-5.17	-3.65	-1.33	-0.76
Price/Book Value High	- -	- -	- -	321.28	-5.67	-4.86	-7.97	-14.24	-8.84	-7.59	-8.51	-6.72	-4.74	-1.65	-1.05
Price/Book Value Low	- -	- -	- -	195.75	-2.96	-2.8	-5.51	-7.93	-5.18	-2.95	-4.59	-3.59	-2.55	-1.01	-0.55
Price/Tangible Book Value	- -	- -	- -	-48.98	56.6	10.02	7.16	6.12	5.73	7.4	5.09	4.28	5.21	2.81	1.96
Price/Tangible Book Value Average	- -	- -	- -	-42.23	66.39	8.69	6.41	7.42	6.87	5.35	5.65	4.4	5.72	3.6	2.23
Price/Tangible Book Value High	- -	- -	- -	-58.01	86.25	10.71	7.91	9.97	9.09	8.07	7.87	5.73	7.43	4.48	3.08
Price/Tangible Book Value Low	- -	- -	- -	-35.34	45.03	6.17	5.46	5.55	5.32	3.14	4.25	3.05	4	2.74	1.62
Price/Sales	- -	- -	- -	1.27	3.06	3.04	3.53	3.24	2.3	3.07	2.84	1.86	1.55	1.06	0.74
Price/Sales Average	- -	- -	- -	1.09	3.59	2.64	3.16	3.93	2.76	2.22	3.16	1.91	1.71	1.36	0.84
Price/Sales High	- -	- -	- -	1.5	4.66	3.25	3.9	5.28	3.65	3.34	4.39	2.48	2.21	1.7	1.17
Price/Sales Low	- -	- -	- -	0.91	2.43	1.87	2.7	2.94	2.14	1.3	2.37	1.32	1.19	1.04	0.61
Price/Cash Flow	- -	- -	- -	14.31	15.95	9.13	14.99	-14.52	-21.53	-877.23	19.1	13.96	32.26	7.27	6.96
Price/Cash Flow Average	- -	- -	- -	12.34	18.71	7.91	13.42	-17.61	-25.82	-633.63	21.23	14.37	35.45	9.31	7.93
Price/Cash Flow High	- -	- -	- -	16.94	24.3	9.76	16.55	-23.65	-34.15	-956	29.54	18.69	46.01	11.58	10.96
Price/Cash Flow Low	- -	- -	- -	10.32	12.69	5.62	11.44	-13.17	-19.99	-372.08	15.95	9.97	24.79	7.09	5.76
Price/Free Cash Flow Average	- -	- -	- -	12.34	18.71	7.98	13.42	-17.61	-25.82	-633.63	21.45	14.49	35.45	9.31	7.93
Price/Free Cash Flow High	- -	- -	- -	16.94	24.3	9.84	16.55	-23.65	-34.15	-956	29.84	18.85	46.01	11.58	10.96
Price/Free Cash Flow Low	- -	- -	- -	10.32	12.69	5.67	11.44	-13.17	-19.99	-372.08	16.12	10.05	24.79	7.09	5.76
EV/Sales Average	- -	0.02	- -	1.38	4.47	3.46	3.76	3.72	2.93	2.41	3.27	2.13	1.89	1.45	0.9
EV/Sales High	- -	0.02	- -	1.78	5.54	4.08	4.49	5.07	3.82	3.54	4.51	2.7	2.39	1.79	1.22
EV/Sales Low	- -	0.02	- -	1.2	3.31	2.7	3.29	2.73	2.31	1.49	2.49	1.54	1.37	1.13	0.67
EV/EBITDA Average	- -	0.1	-0.11	12.81	-32.35	-46.76	140.04	71.38	-108.72	-537.93	-2,745.84	17.49	25.25	11.63	11.63
EV/EBITDA High	- -	0.1	-0.11	16.6	-40.12	-55.07	167.53	97.26	-141.72	-789.78	-3,782.34	22.21	32.05	14.29	15.81
EV/EBITDA Low	- -	0.1	-0.11	11.15	-23.99	-36.42	122.59	52.38	-85.61	-333.59	-2,087.85	12.69	18.38	9.02	8.65
EV/EBIT Average	- -	0.12	-0.14	24.41	-16.76	-18.29	-53.29	4,853.72	-36.7	-37.34	-49.28	41	302.36	24.69	41.01
EV/EBIT High	- -	0.12	-0.14	31.64	-20.78	-21.55	-63.75	6,613.82	-47.83	-54.82	-67.89	52.06	383.84	30.35	55.74
EV/EBIT Low	- -	0.12	-0.14	21.25	-12.43	-14.25	-46.65	3,561.87	-28.9	-23.16	-37.47	29.73	220.13	19.16	30.51
Last Price	- -	- -	- -	45.47	33.41	36.98	46.18	44.79	33.7	45.88	34.67	27.06	22.43	15.92	11.23
High Price	- -	- -	- -	53.85	50.92	39.53	50.99	72.96	53.45	50	53.61	36.22	31.99	25.36	17.69
Enterprise Value Average	- -	28	-32	2,302	2,274	1,959	2,297	2,427	2,044	1,721	1,922	1,456	1,270	1,000	632
Enterprise Value High	- -	28	-32	2,983	2,820	2,308	2,748	3,307	2,664	2,527	2,648	1,848	1,612	1,229	858
Enterprise Value Low	- -	28	-32	2,004	1,687	1,526	2,010	1,781	1,610	1,067	1,461	1,055	925	776	470

Shares Outstanding	- -	47	47	47	47	47	47	47	48	48	48	47	46	46	46
Diluted Weighted Avg Shares	47	47	47	47	47	47	47	47	48	48	49	47	47	46	46
Basic Weighted Avg Shares	47	47	47	47	47	47	47	47	48	48	48	47	47	46	46
Revenue per Share	35.69	36.2	36.06	35.93	10.93	12.15	13.07	13.82	14.66	14.95	12.2	14.59	14.45	14.95	15.14
EBITDA per Share	5.63	6.14	6.33	3.86	-1.51	-0.9	0.35	0.72	-0.39	-0.07	-0.01	1.77	1.08	1.87	1.17
Operating Income per Share	4.53	4.9	4.84	2.03	-2.91	-2.3	-0.92	0.01	-1.17	-0.96	-0.81	0.76	0.09	0.88	0.33
Basic EPS, GAAP	3.06	3.28	3.32	0.58	-9.15	0.85	1.69	1.22	-0.96	-0.57	0.13	1.08	-1.33	-8.52	-1.57
Basic EPS from Cont Ops	3.06	3.28	3.32	0.58	-2.17	-1.79	-0.69	-0.18	-0.96	-0.57	-0.64	0.46	-0.21	-8.4	-1.57
Diluted EPS, GAAP	3.06	3.28	3.32	0.58	-9.15	0.85	1.69	1.22	-0.96	-0.57	0.13	1.07	-1.33	-8.52	-1.57
Diluted EPS from Cont Ops	3.06	3.28	3.32	0.58	-2.17	-1.77	-0.69	-0.18	-0.96	-0.57	-0.64	0.45	-0.21	-8.4	-1.57
Dividend per Share	- -	- -	- -	14.61	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	3	4.36	4.81	3.18	2.1	4.05	3.08	-3.08	-1.57	-0.05	1.81	1.94	0.7	2.19	1.61
Free Cash Flow per Basic Share	3	4.36	4.81	3.18	2.1	4.05	3.08	-3.08	-1.57	-0.05	1.81	1.94	0.7	2.19	1.61
Cash & Equivalents per Share	- -	1.03	0.95	3.2	2.78	2.44	4.69	8.15	4.31	2.33	2.46	2.72	1.88	2.34	1.94
Book Value per Share	- -	- -	- -	0.17	-8.98	-8.13	-6.4	-5.12	-6.05	-6.59	-6.3	-5.39	-6.75	-15.36	-16.83
Tangible Book Value per Share	- -	9.56	10.92	-0.93	0.59	3.69	6.45	7.32	5.88	6.2	6.81	6.33	4.31	5.67	5.73

Avanos Medical, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)